ArticleJournal of cancer research and clinical oncology2023

Immunological effects and activity of multiple doses of zolbetuximab in combination with zoledronic acid and interleukin-2 in a phase 1 study in patients with advanced gastric and gastroesophageal junction cancer.

Florian Lordick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.